Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tobacco-Flavored vs. Non-Tobacco Flavored E-Cigarettes on Smoking Behavior
NCT06260683Recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Apr 2024
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Randomised, open-label trial in Tobacco Use Disorder (TUD) (3 arms), sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: 7-day point prevalence complete switching rate at 14 weeks, Biochemically verified 7-day point prevalence abstinence from cigarettes at 14 weeks and 1 more. Started Apr 2024; status: recruiting.
02
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT06260683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06260683.